Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Current Leases (2019 - 2025)

Historic Current Leases for OptimizeRx (OPRX) over the last 7 years, with Q3 2025 value amounting to $207000.0.

  • OptimizeRx's Current Leases rose 615.38% to $207000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $207000.0, marking a year-over-year increase of 615.38%. This contributed to the annual value of $168000.0 for FY2024, which is 2432.43% down from last year.
  • According to the latest figures from Q3 2025, OptimizeRx's Current Leases is $207000.0, which was up 615.38% from $209000.0 recorded in Q2 2025.
  • OptimizeRx's 5-year Current Leases high stood at $233000.0 for Q1 2024, and its period low was $14545.0 during Q2 2023.
  • Moreover, its 5-year median value for Current Leases was $110271.0 (2021), whereas its average is $131464.6.
  • Per our database at Business Quant, OptimizeRx's Current Leases tumbled by 8340.99% in 2023 and then soared by 140567.21% in 2024.
  • Quarter analysis of 5 years shows OptimizeRx's Current Leases stood at $90982.0 in 2021, then fell by 1.19% to $89902.0 in 2022, then soared by 146.94% to $222000.0 in 2023, then decreased by 24.32% to $168000.0 in 2024, then increased by 23.21% to $207000.0 in 2025.
  • Its last three reported values are $207000.0 in Q3 2025, $209000.0 for Q2 2025, and $139000.0 during Q1 2025.